BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 21779323)

  • 1. Antimalarial activity of potential inhibitors of Plasmodium falciparum lactate dehydrogenase enzyme selected by docking studies.
    Penna-Coutinho J; Cortopassi WA; Oliveira AA; França TC; Krettli AU
    PLoS One; 2011; 6(7):e21237. PubMed ID: 21779323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimalarial activity and mechanisms of action of two novel 4-aminoquinolines against chloroquine-resistant parasites.
    Aguiar AC; Santos Rde M; Figueiredo FJ; Cortopassi WA; Pimentel AS; França TC; Meneghetti MR; Krettli AU
    PLoS One; 2012; 7(5):e37259. PubMed ID: 22649514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimalarial properties and molecular docking analysis of compounds from Dioscorea bulbifera L. as new antimalarial agent candidates.
    Chaniad P; Mungthin M; Payaka A; Viriyavejakul P; Punsawad C
    BMC Complement Med Ther; 2021 May; 21(1):144. PubMed ID: 34006257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple e-pharmacophore modelling pooled with high-throughput virtual screening, docking and molecular dynamics simulations to discover potential inhibitors of Plasmodium falciparum lactate dehydrogenase (PfLDH).
    Saxena S; Durgam L; Guruprasad L
    J Biomol Struct Dyn; 2019 Apr; 37(7):1783-1799. PubMed ID: 29718775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiplasmodial activity of chloroquine analogs against chloroquine-resistant parasites, docking studies and mechanisms of drug action.
    de Souza NB; Carmo AM; da Silva AD; França TC; Krettli AU
    Malar J; 2014 Dec; 13():469. PubMed ID: 25440372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and activity of a series of azole-based compounds with lactate dehydrogenase-directed anti-malarial activity.
    Cameron A; Read J; Tranter R; Winter VJ; Sessions RB; Brady RL; Vivas L; Easton A; Kendrick H; Croft SL; Barros D; Lavandera JL; Martin JJ; Risco F; García-Ochoa S; Gamo FJ; Sanz L; Leon L; Ruiz JR; Gabarró R; Mallo A; Gómez de las Heras F
    J Biol Chem; 2004 Jul; 279(30):31429-39. PubMed ID: 15117937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1,2,3-Triazole derivatives: synthesis, docking, cytotoxicity analysis and in vivo antimalarial activity.
    Valério Lopes F; Fazza Stroppa PH; Marinho JA; Reis Soares R; de Azevedo Alves L; Capriles Goliatt PVZ; Abramo C; David da Silva A
    Chem Biol Interact; 2021 Dec; 350():109688. PubMed ID: 34627786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Commercial drugs containing flavonoids are active in mice with malaria and in vitro against chloroquine-resistant Plasmodium falciparum.
    Penna-Coutinho J; Aguiar AC; Krettli/ AU
    Mem Inst Oswaldo Cruz; 2018 Dec; 113(12):e180279. PubMed ID: 30540020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the drug susceptibility of Plasmodium falciparum clinical isolates from africa by using a Plasmodium lactate dehydrogenase immunodetection assay and an inhibitory maximum effect model for precise measurement of the 50-percent inhibitory concentration.
    Kaddouri H; Nakache S; Houzé S; Mentré F; Le Bras J
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3343-9. PubMed ID: 17005815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative structural analysis and kinetic properties of lactate dehydrogenases from the four species of human malarial parasites.
    Brown WM; Yowell CA; Hoard A; Vander Jagt TA; Hunsaker LA; Deck LM; Royer RE; Piper RC; Dame JB; Makler MT; Vander Jagt DL
    Biochemistry; 2004 May; 43(20):6219-29. PubMed ID: 15147206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of oxamic acid libraries: antimalarials and inhibitors of Plasmodium falciparum lactate dehydrogenase.
    Choi SR; Beeler AB; Pradhan A; Watkins EB; Rimoldi JM; Tekwani B; Avery MA
    J Comb Chem; 2007; 9(2):292-300. PubMed ID: 17316052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Docking studies on the binding of quinoline derivatives and hematin to Plasmodium falciparum lactate dehydrogenase.
    Cortopassi WA; Oliveira AA; Guimarães AP; Rennó MN; Krettli AU; França TC
    J Biomol Struct Dyn; 2011 Aug; 29(1):207-18. PubMed ID: 21696234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atorvastatin is a promising partner for antimalarial drugs in treatment of Plasmodium falciparum malaria.
    Parquet V; Briolant S; Torrentino-Madamet M; Henry M; Almeras L; Amalvict R; Baret E; Fusaï T; Rogier C; Pradines B
    Antimicrob Agents Chemother; 2009 Jun; 53(6):2248-52. PubMed ID: 19307369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly potent anti-malarial activity of benzopyrano(4,3-b)benzopyran derivatives and
    Joshi N; Hada R; Gupta S; Khan J; Dobrowolski J; Dhar PK; Kumar N; Singh S
    J Biomol Struct Dyn; 2022 Jul; 40(11):5159-5174. PubMed ID: 33416018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statins as potential antimalarial drugs: low relative potency and lack of synergy with conventional antimalarial drugs.
    Wong RP; Davis TM
    Antimicrob Agents Chemother; 2009 May; 53(5):2212-4. PubMed ID: 19258270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atorvastatin is 10-fold more active in vitro than other statins against Plasmodium falciparum.
    Pradines B; Torrentino-Madamet M; Fontaine A; Henry M; Baret E; Mosnier J; Briolant S; Fusai T; Rogier C
    Antimicrob Agents Chemother; 2007 Jul; 51(7):2654-5. PubMed ID: 17502414
    [No Abstract]   [Full Text] [Related]  

  • 17. In silico and in vivo anti-malarial investigation on 1-(heteroaryl)-2-((5-nitroheteroaryl)methylene) hydrazine derivatives.
    Tahghighi A; Mohamadi-Zarch SM; Rahimi H; Marashiyan M; Maleki-Ravasan N; Eslamifar A
    Malar J; 2020 Jun; 19(1):231. PubMed ID: 32600425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmodium falciparum: stage specific effects of a selective inhibitor of lactate dehydrogenase.
    Vivas L; Easton A; Kendrick H; Cameron A; Lavandera JL; Barros D; de las Heras FG; Brady RL; Croft SL
    Exp Parasitol; 2005 Oct; 111(2):105-14. PubMed ID: 16098967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, and biological evaluation of Plasmodium falciparum lactate dehydrogenase inhibitors.
    Choi SR; Pradhan A; Hammond NL; Chittiboyina AG; Tekwani BL; Avery MA
    J Med Chem; 2007 Aug; 50(16):3841-50. PubMed ID: 17636950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic Characteristics of Lactate Dehydrogenase on a Multiplex Assay for Malaria Detection Including the Zoonotic Parasite Plasmodium knowlesi.
    Barney R; Velasco M; Cooper CA; Rashid A; Kyle DE; Moon RW; Domingo GJ; Jang IK
    Am J Trop Med Hyg; 2021 Nov; 106(1):275-282. PubMed ID: 34781260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.